REPL vs STT · $825.7M cap vs P/E 17, $45.02B cap
Replimune Group Inc (REPL) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
State Street Corp (STT) is a asset management company listed on US.
REPL does not have a complete income-statement cache yet.
STT does not have a complete income-statement cache yet.
REPL currently screens at market cap $825.7M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the REPL and STT stock pages for the full models.
Not investment advice.